These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 35970222)

  • 61. Optimal therapy of low levels of high density lipoprotein-cholesterol.
    Kashyap ML; Tavintharan S; Kamanna VS
    Am J Cardiovasc Drugs; 2003; 3(1):53-65. PubMed ID: 14727946
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
    Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
    Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
    Dansinger ML; Williams PT; Superko HR; Schaefer EJ
    Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of Low-density Lipoprotein Cholesterol on Coronary Artery Calcification Progression According to High-density Lipoprotein Cholesterol Levels.
    Lee DY; Kim JH; Park SE; Park CY; Oh KW; Park SW; Rhee EJ; Lee WY
    Arch Med Res; 2017 Apr; 48(3):284-291. PubMed ID: 28923331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
    Yokoyama K; Tani S; Matsuo R; Matsumoto N
    Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
    Nimkuntod P; Tongdee P
    J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence of combined and noncombined dyslipidemia in an Iranian population.
    Darroudi S; Saberi-Karimian M; Tayefi M; Arekhi S; Motamedzadeh Torghabeh A; Seyedzadeh Sani SMR; Moohebati M; Heidari-Bakavoli A; Ebrahimi M; Azarpajouh MR; Safarian M; A Ferns G; Esmaeili H; Parizadeh MR; Mokhber N; Mahdizadeh A; Mahmoudi AA; Sahebkar AH; Ghayour-Mobarhan M
    J Clin Lab Anal; 2018 Oct; 32(8):e22579. PubMed ID: 29926995
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Association between high-density lipoprotein cholesterol level and cardiovascular disease and all-cause mortality in the elderly population].
    Yu JX; Wu SL; Chen SH; Liu Y; Feng MK; Yang Y; Li SJ; Liu XK; Yang N; Li YM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Aug; 50(8):791-798. PubMed ID: 35982012
    [No Abstract]   [Full Text] [Related]  

  • 75. Differences in predictors of incident heart failure according to atherosclerotic cardiovascular disease status.
    Dawson LP; Carrington MJ; Haregu T; Nanayakkara S; Jennings G; Dart A; Stub D; Kaye D
    ESC Heart Fail; 2023 Dec; 10(6):3398-3409. PubMed ID: 37688465
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
    AIM-HIGH Investigators
    Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
    Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
    Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
    Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
    J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial.
    Li D; Xu T; Xie D; Wang M; Sun S; Wang M; Zhang S; Yang X; Zhang Z; Wang S; Kuang M; Tang J; Liu H; Hong X; Fu G; Zhang W
    J Med Internet Res; 2023 Apr; 25():e44939. PubMed ID: 37043273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.